54 reports of this reaction
5.6% of all PHENOBARBITAL SODIUM reports
#3 most reported adverse reaction
DRUG INEFFECTIVE is the #3 most commonly reported adverse reaction for PHENOBARBITAL SODIUM, manufactured by BPI Labs LLC. There are 54 FDA adverse event reports linking PHENOBARBITAL SODIUM to DRUG INEFFECTIVE. This represents approximately 5.6% of all 956 adverse event reports for this drug.
Patients taking PHENOBARBITAL SODIUM who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among PHENOBARBITAL SODIUM users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for PHENOBARBITAL SODIUM:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 54 FDA reports for PHENOBARBITAL SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 5.6% of all adverse event reports for PHENOBARBITAL SODIUM, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking PHENOBARBITAL SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.